An antiangiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma
- 1 March 1997
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 37 (5) , 1107-1113
- https://doi.org/10.1016/s0360-3016(96)00628-1
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Impact of overall treatment time of fractionated irradiation on local control of human FaDu squamous cell carcinoma in nude miceRadiotherapy and Oncology, 1994
- The combination of antiagniogenic agents to inhibit primary tumor growth and metastasisJournal of Pediatric Surgery, 1993
- Analysis of experimental antiangiogenic therapyJournal of Pediatric Surgery, 1993
- Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: Results from the EORTC cooperative trial 22851Seminars in Radiation Oncology, 1992
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Oxygen delivery to tumorsInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Tumor AngiogenesisPublished by Elsevier ,1985
- Tumor Microvasculature Following Fractionated X IrradiationRadiology, 1975
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971